Researchers at the University of Massachusetts Medical School are trying to develop an alternative way to prevent Lyme disease infection: a drug that could be administered to those at risk annually, just before tick season, the Boston Globe reported.
Though it sounds like the flu shot, the drug is not a vaccine, which activates the immune system against an invader. Instead, it is a pre-exposure prophylaxis, a molecule ready to kill bacteria immediately, similar to pills taken to ward off malaria when traveling abroad. “You take the medicine before you’re going to be exposed,” says lead researcher Mark Klempner, executive vice chancellor at MassBiologics, the nonprofit drug research and manufacturing arm of UMass.
Klempner and colleagues presented positive results from mouse studies at two infectious disease conferences last month, but the details have yet to be reviewed by other scientists or published.
Click here to read the entire article
Source: Boston Globe
Latest from Pest Control Technology
- Envu Announces Launch of New Rewards Program
- Regulations, Science and Strategy Take Center Stage at Purdue Conference
- Selling Pest Control in the 21st Century
- Purdue Pest Management Conference Marks 90 Years
- Rentokil Initial Appoints Mike Duffy as CEO
- Harry Bryan Named VP of Business Development for Nisus Corporation
- Douglas Products Announces Planned CEO Transition
- Industry Veteran Richard Cruz Joins VM Products
